CytRx Co. (OTCMKTS:CYTR) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.01 and traded as high as $2.74. CytRx shares last traded at $2.53, with a volume of 84,938 shares traded.
The firm’s 50 day simple moving average is $2.79 and its 200-day simple moving average is $2.01.
About CytRx (OTCMKTS:CYTR)
CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor.
Featured Story: What Is Dividend Yield and How Do You Calculate It?
Receive News & Ratings for CytRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CytRx and related companies with MarketBeat.com's FREE daily email newsletter.